Completed Phase I, Dose Escalation Study of Decitabine NCT02264873 Conditions Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +19 more Locations UF Health Shands Hospital — Gainesville, Florida, United States View Trial Details